Medicared For All Logo

Radwan Kesserwan in Oklahoma City, Oklahoma

Home Oklahoma Oklahoma City

Radwan Kesserwan has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 1000 N Lee Ave in Oklahoma City, Oklahoma. There is an additional office location, for a total of two, for Radwan Kesserwan that can be viewed further down.

They're a part of the: Ssm Health Care Of Oklahoma, Inc. medical group which has around 37 members. You can call their office at 405-272-7278 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1992 (around 32 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Radwan Kesserwan Office Phone and Directions

Radwan Kesserwan
Ssm Health Care Of Oklahoma, Inc.
1000 N Lee Ave
Oklahoma City, Oklahoma 73102
405-272-7278


Patient Ratings
Please rate your experience with Radwan Kesserwan below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 405-272-7278


Enter a starting address:


Healthcare Info for Radwan Kesserwan

Medical School: Sorry, his university is not listed
Graduation Year: 1992
The Primary Medical Specialty for Radwan Kesserwan is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 32
PAC (PECOS ID)#: 0648450247
NPI #: 1245324433
NPI Created On: 10/03/2006
NPI Last Updated Listed as: 10/21/2020
Primary Taxonomy Code: 207R00000X
License Number:
22414
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, HEBREW, FRENCH, ENGLISH.


Services and Procedures include:

  1. Review and interpretation of external ekg recording for more than 48 hours up to 21 days
  2. Routine ekg using at least 12 leads including interpretation and report
  3. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  4. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  5. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
  6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
  7. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
  8. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
  9. Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
  10. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  11. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  12. Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
  13. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
  14. Ultrasound scan of vena cava or groin graft or vessel blood flow
  15. New patient office or other outpatient visit, typically 45 minutes
  16. New patient office or other outpatient visit, typically 60 minutes
  17. Established patient office or other outpatient, visit typically 25 minutes
  18. Established patient office or other outpatient, visit typically 40 minutes
  19. Initial hospital inpatient care, typically 50 minutes per day
  20. Initial hospital inpatient care, typically 70 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $7

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504589

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Payments Total: $3

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504593

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Payments Total: $6

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504597

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Payments Total: $12

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504603

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Payments Total: $10

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504607

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Payments Total: $7

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504611

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Payments Total: $9

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504617

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Payments Total: $9

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504635

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Payments Total: $9

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504621

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Payments Total: $9

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 805504625

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: Livalo

Open Associated Drug #1: 66869-404-07

Drug or Biological: Drug

Product Category #2: Cardiovascular

Name Of Drug #2:: Bystolic

Associated Drug #2: 0456-1405-01


Additional Office Locations

1. Saint Medical Group, Llc
608 Nw 9th St
Oklahoma City, OK 73102
Suite 1100
Group Members: 302

Phone: 405-272-7278

Enter a starting address:


Cardiovascular Disease (cardiology) Professionals in Oklahoma City

608 Nw9th St
Oklahoma-city, OK

608 Nw 9th St
Oklahoma-city, OK

608 Nw 9th St
Oklahoma-city, OK
Ssm Health Care Of Oklahoma, Inc.

1000 N Lee Ave
Oklahoma-city, OK
Ssm Health Care Of Oklahoma, Inc.

608 Nw 9th St
Oklahoma-city, OK
Saint Medical Group, Llc

4221 S Western Ave
Oklahoma-city, OK
Integris Cardiovascular Physicians Llc

Providers in Ssm Health Care Of Oklahoma, Inc.

1.Dean Baustert Cna

1000 N Lee Ave
Oklahoma City Ok 73102-1036
Ssm Health Care Of Oklahoma, Inc.
Certified Registered Nurse Anesthetist (crna)

2.Ting-kon Chen

1000 N Lee Ave
Oklahoma City Ok 73102-1036
Ssm Health Care Of Oklahoma, Inc.
Anesthesiology

3.Asim Chohan Md

2825 Parklawn Dr
Midwest City Ok 73110-4201
Ssm Health Care Of Oklahoma, Inc.
Cardiovascular Disease (cardiology)

4.Sandeep Chopra Md

1000 N Lee Ave
Oklahoma City Ok 73102-1036
Ssm Health Care Of Oklahoma, Inc.
Cardiovascular Disease (cardiology)

5.Sandeep Chopra Md

2129 Sw 59th St
Oklahoma City Ok 73119-7024
Ssm Health Care Of Oklahoma, Inc.
Cardiovascular Disease (cardiology)

6.William Collazo Md

1000 N Lee Ave
Oklahoma City Ok 73102-1036
Ssm Health Care Of Oklahoma, Inc.
Cardiovascular Disease (cardiology)

View all 37 members of Ssm Health Care Of Oklahoma, Inc. medical group